Short-term discontinuation of HAART regimens more common in vulnerable patient populations. - Wikidata - awgldk - TriplyDB

Short-term discontinuation of HAART regimens more common in vulnerable patient populations.

Short-term discontinuation of HAART regimens more common in vulnerable patient populations.

http://www.wikidata.org/entity/Q34085103

about

A systematic review of behavioral and treatment outcome studies among HIV-infected men who have sex with men who abuse crystal methamphetamine Influence of adverse drug reactions on treatment success: prospective cohort analysis of HIV-infected individuals initiating first-line antiretroviral therapy in India Reasons and Risk Factors for the Initial Regimen Modification in Chinese Treatment-Naïve Patients with HIV Infection: A Retrospective Cohort Analysis Using administrative claims data to estimate virologic failure rates among human immunodeficiency virus-infected patients with antiretroviral regimen switches.Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study.Association of pharmacogenetic markers with premature discontinuation of first-line anti-HIV therapy: an observational cohort study.Anti-HIV drug-combination nanoparticles enhance plasma drug exposure duration as well as triple-drug combination levels in cells within lymph nodes and blood in primates.Implementation of mental health service has an impact on retention in HIV care: a nested case-control study in a japanese HIV care facility.Changes in first-line cART regimens and short-term clinical outcome between 1996 and 2010 in The Netherlands The urgency of providing comprehensive and integrated treatment for substance abusers with HIV Challenges in managing HIV in people who use drugs Acupuncture and the relaxation response for treating gastrointestinal symptoms in HIV patients on highly active antiretroviral therapy.Cocaine-mediated impact on HIV infection in humanized BLT mice.Prevalence of Drug Resistance and Associated Mutations in a Population of HIV-1(+) Puerto Ricans: 2006-2010.Correlates of antiretroviral utilization among hospitalized HIV-infected crack cocaine users.How are women living with HIV in France coping with their perceived side effects of antiretroviral therapy? Results from the EVE study.Baseline clinical characteristics, antiretroviral therapy use, and viral load suppression among HIV-positive young men of color who have sex with men.Utility of an interactive voice response system to assess antiretroviral pharmacotherapy adherence among substance users living with HIV/AIDS in the rural South The effects of cocaine on HIV transcription Toxicity-related antiretroviral drug treatment modifications in individuals starting therapy: a cohort analysis of time patterns, sex, and other risk factors.The association of clinical follow-up intervals in HIV-infected persons with viral suppression on subsequent viral suppression.Discontinuation of antiretroviral therapy among adults receiving HIV care in the United States.Saquinavir Loaded Acetalated Dextran Microconfetti - a Long Acting Protease Inhibitor Injectable.The influence of patient beliefs and treatment satisfaction on the discontinuation of current first-line antiretroviral regimens.Durability of the first antiretroviral treatment regimen and reasons for change in patients with HIV infection.Sex differences in adherence to highly active antiretroviral therapy: a meta-analysis.Editorial Commentary: Affordable Care Act, Medicaid Expansion … or Not: Ryan White Care Act Remains Essential for Access and Equity.

P2860

Q27027539-4EF7E958-B5AB-483F-B0AA-0F5EF2ECC452 Q28540682-CC20914A-FB84-4F44-960B-B05AE6F02AEE Q28546795-2537130E-D791-488C-9E37-E1D13F778C64 Q33879444-336916B0-2EDA-4761-915C-339AB472614C Q34474961-D18A543D-B427-4B7C-BC5A-2AF99AEF64B9 Q34763589-36F2FE92-48BE-44F1-B461-F7A9AC98DAD9 Q34869449-14A6EB96-06EE-4DE0-BA6C-C12F9EAB2407 Q34903194-F4FA5CF6-D7F0-43BC-9340-7292784023CA Q35010207-3098654E-770A-4F46-BA8E-5889C8C5BCD1 Q35308404-8A461DBB-B452-43C6-8D5A-68EBA6ED68FD Q35538674-AE9CE202-EA3F-44A2-9001-0AC6E4CD972A Q35596698-04247C63-2BC2-4A5B-931A-D5EE3D320BE0 Q35754062-304B6B11-96ED-4C82-817E-3478FC9B49B1 Q35944787-9B292D4D-95FD-4B9B-8A38-EFDBE0490D5F Q36177517-DE8FBD1F-9090-4086-850F-1F5410C45328 Q36298353-B9A34DDB-9B45-40C9-AEB6-239EE464A5CC Q36730278-74A0669D-85CF-4CDC-BAA3-379FA5D3FAF7 Q36836520-E5D2DEBD-5A2F-4E41-81F1-B44679434751 Q36906001-26F9AE75-9C5F-45BC-A76A-355FE04FE565 Q36954711-92771052-C850-4B2C-93F0-E60197621BD1 Q37086072-7EFE5E1D-2D04-43E5-8123-D79D73C3DE77 Q37388428-6AE81E14-85B3-4677-8460-F0908B846191 Q39787241-DBBB140E-A1DE-47CE-AFD9-6F697F08431F Q40763424-1C81FCA2-0466-4FC8-8E4C-EDA4186F97CC Q42228869-799BF303-2630-4408-A76B-872FF79133A4 Q45024810-F8AAA1B4-F4F5-44F5-9347-06150E501D68 Q54603807-8B7C06DB-3A31-42F7-9106-6D2A15D5C99C

P2860

Short-term discontinuation of HAART regimens more common in vulnerable patient populations.

http://www.wikidata.org/entity/Q34085103

description

2008 nî lūn-bûn

@nan

2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Short-term discontinuation of ...... ulnerable patient populations.

@ast

Short-term discontinuation of ...... ulnerable patient populations.

@en

Short-term discontinuation of ...... ulnerable patient populations.

@nl

type

label

Short-term discontinuation of ...... ulnerable patient populations.

@ast

Short-term discontinuation of ...... ulnerable patient populations.

@en

Short-term discontinuation of ...... ulnerable patient populations.

@nl

prefLabel

Short-term discontinuation of ...... ulnerable patient populations.

@ast

Short-term discontinuation of ...... ulnerable patient populations.

@en

Short-term discontinuation of ...... ulnerable patient populations.

@nl

P1433

Q34085103-98165BA9-CFDA-4B4D-AC8D-C23C7986EF5D

P1476

Q34085103-46D27021-6B44-4346-9B13-49C507EB42C4

P2093

Q34085103-1FF1C359-AECE-43B9-BD69-0D680E07E0EE

Q34085103-200B557A-BCCA-4994-81A3-AF5E7BF99D88

Q34085103-210F8E23-93AC-4F99-8532-5FEFFF95D652

Q34085103-3071BB33-5D5A-4DEC-A598-2E172E4B8C60

Q34085103-BA7FFCA7-A7AA-40F0-9437-A92CD9C278BA

Q34085103-CE422D00-0276-4C38-991E-36D0F361E6E6

Q34085103-D47E58A1-1F36-430C-B2E3-E2B1365F5049

Q34085103-EAD45EFA-ADEF-4F11-B485-8B95EBA1A5B7

P2860

Q34085103-0528A164-8AFC-40D9-A99D-21588A7D2E98

Q34085103-057BB286-3DE5-4DA2-8484-DBBB30E418C8

Q34085103-11B57C5C-C75C-44B6-A2AA-C235D8196199

Q34085103-12451690-C123-4D82-A4E2-C08B0F26CD25

Q34085103-12F1F17B-A8DB-4172-8473-0E58AA6DC848

Q34085103-2B830A21-5B38-4655-B4BD-F9DF17ABBC0F

Q34085103-42207A09-B17A-4031-A31D-DCAD453FADF6

Q34085103-42B0F556-7BB7-4B47-B0BA-6E7618A2BF54

Q34085103-447BFEB6-94FE-4E73-B463-37680CBF8B22

Q34085103-515A6143-6464-49BD-954F-832F0C930997

P304

Q34085103-EA2EC2C2-D215-4EB9-90B5-71412DB03571

P31

Q34085103-A7B267BA-11D7-43A4-8622-55CB8773BCDE

P356

Q34085103-98098814-C4BE-4BB8-9229-F033FACAC4DA

P433

Q34085103-1092499A-605D-44E5-B172-2ECF50BA388B

P478

Q34085103-DDEB029C-B5F1-4140-B42E-D55A701BBF6E

P50

Q34085103-175AAD94-EAA3-4EB2-AC53-95D5D3740B88

Q34085103-C62AFEDE-865A-47F3-B5B4-695B8FB14780

P577

Q34085103-627EB4D1-63C5-4D19-8C52-51BB456C26D0

P5875

Q34085103-C359DE58-8193-46AD-A345-F08AE9C70EA2

P698

Q34085103-C8E1C4EE-06F9-4C82-BFD5-0ED34E872D90

P921

Q34085103-D4BAF6CE-2A72-4125-8CD1-5BDEBEB2C38E

P932

Q34085103-628C7EF9-3741-4575-9C59-3AE9249720C4

P356

P1433

AIDS Research and Human Retroviruses

P1476

Short-term discontinuation of ...... ulnerable patient populations.

@en

P2093

C Mel Wilcox

http://www.w3.org/2001/XMLSchema#string

James H Willig

http://www.w3.org/2001/XMLSchema#string

James L Raper

http://www.w3.org/2001/XMLSchema#string

Lindsay S Robison

http://www.w3.org/2001/XMLSchema#string

Michael J Mugavero

http://www.w3.org/2001/XMLSchema#string

Michael S Saag

http://www.w3.org/2001/XMLSchema#string

Mirjam C Kempf

http://www.w3.org/2001/XMLSchema#string

Stephen R Cole

http://www.w3.org/2001/XMLSchema#string

P2860

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

HIV infection in women in the United States: status at the Millennium.

Sex differences in adverse reactions to antiretroviral drugs.

Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial.

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients.

Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions.

Patterns and correlates of discontinuation of the initial HAART regimen in an urban outpatient cohort.

Determinants of sustained virological suppression in indigent, HIV-infected patients: is single protease inhibitor-based antiretroviral therapy truly highly active?

Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: a comparison with self-reported symptoms. Outcomes Committee of the AIDS Clinical Trials Group.

The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group.

P304

1347-1355

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/AID.2008.0083

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Jeroan J. Allison

Andrew O Westfall

P577

2008-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45523310

http://www.w3.org/2001/XMLSchema#string

P698

19032064

http://www.w3.org/2001/XMLSchema#string

P921

P932

2928492

http://www.w3.org/2001/XMLSchema#string